Fred van Leuven
Corporate Officer/Principal bij Katholieke Universiteit Leuven
Profiel
Fred van Leuven is the founder of AC Immune SA and reMYND NV, both founded in 2003 and 2002 respectively.
He is currently a Professor at Katholieke Universiteit Leuven.
Dr. van Leuven received a doctorate degree from Ghent University in 1976 and a graduate degree from the same university in 1970.
Actieve functies van Fred van Leuven
| Bedrijven | Functie | Begin |
|---|---|---|
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - |
Eerdere bekende functies van Fred van Leuven
| Bedrijven | Functie | Einde |
|---|---|---|
| AC IMMUNE SA | Founder | - |
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Founder | - |
Opleiding van Fred van Leuven
| Ghent University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
